The differential diagnosis between G3-NET and NEC in difficult cases can be made by integrating the Ki67 proliferative index with p53 and Rb immunohistochemistry, since most NECs show TP53 and RB mutations and consequent p53 and Rb aberrant immunohistochemical expression. Here, MKI67 is linked to neuroendocrine carcinoma.